Neratinib Plus Fulvestrant Combination Does Not Meet Efficacy Criteria for Metastatic Breast Cancer
With the coming Oil & Gas Asia Exhibition in Pakistan, ECHEMI rolls out a new bulk purchasing activity for its new and old customers. This activity will be valid before March 16 when the exhibition come to the end. The more you buy, the more money you will save.
How to join this bulk purchasing?
You can enjoy the most favorable prices via three steps:
First, you should come to the home page of ECHEMI, then you can see the the following page:
Second, input your demand and submit the inquiry.
Third, ECHEMI will give you a reply within 1 working day after receiving your inquiry.
Opportunity knocks but once! Come on, seize this opportunity right now!
Looking for chemical products? Let suppliers reach out to you!
You May Interested In
β-Nicotinamide Adenine Dinucleotide High Quality NAD+ CAS 53-84-9 Exclusive Production Factory CAS NO.53-84-9
$75/UNIT FOB
2026-06-20
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
EFSA Reaffirms Safety of E948 Oxygen and E949 Hydrogen in All Foods No Health Risks Detected
-
EFSA Confirms Safety of Vitamin E TPGS as Food Additive New Opinion Covers Multiple Use Levels
-
Indian Pharma Urges US to Exempt Generics as 50 Percent Tariffs Loom National Security Probe Sparks Supply Fears
-
China Signals Openness to WTO Reforms Tariff Talks Ahead of 2026 Meeting
-
China Extends Anti-Dumping Duties Up to 103.1 Percent on Steel Imports
-
Rising API Costs Threaten Drug Prices
-
Innogen Targets 2026 Obesity Drug Market With Trials to Wrap in 2025
-
Lilly Bets Bigger on China
-
AbbVie Invests $2.1 Billion in Capstan Therapeutics Transforming CAR-T Landscape
-
32 Pharma Deals in 2025 First Half Signal Industry Shift Amid Policy Uncertainty
Recommend Reading
-
US Vietnam Trade Deal Slashes Tariffs to 20 Percent Avoids Economic Clash
-
US Resumes Ethane Exports to China 240000 Barrels Per Day Back on Track
-
Hengrui Strikes $500 Million Global Drug Deal with GSK Potential Payouts Up to $12 Billion
-
NHU Projects Profit Surge of Up to 70 Percent in H1 2025 Reaching 37.5 Billion Yuan
-
Torrent Pharma Targets First Wave Semaglutide Launch Revenue Up 11 Percent as Patent Ends
-
Methanol market trends fluctuate downward in China
-
Weak Consolidation in the Ethanol Market in China
-
Ammonium Sulfate Market at High Level Consolidation (10.17-10.23)
-
This Week, China's Acetone Market Continues to Show Weakness (8.15-22)
-
Weak Demand Leads to Slight Decline in Ammonium Sulfate Prices (8.18-8.22)